Alpha 2.0
Login Register
» Authors » Victor Sapena

Victor Sapena

Explore the profile of Victor Sapena including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 43
Citations 386
Followers 0
Related Specialties
Gastroenterology
Oncology
Radiology
Top 10 Co-Authors
Maria Reig
Jordi Bruix
Alejandro Forner
Marco Sanduzzi-Zamparelli
Ferran Torres
Carmen Ayuso
Jordi Rimola
Anna Darnell
Jose Rios
Neus Llarch
Published In
J Hepatol
Hepatology
Liver Int
Aliment Pharmacol Ther
Eur Radiol
Affiliations
Soon will be listed here.
Recent Articles
1.
Liver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA HCV therapy: lifestyle changes and liver cancer risk
Granel N, Iserte G, Bartres C, Llarch N, Pla A, Sapena V, et al.
BMC Gastroenterol . 2025 Feb; 25(1):51. PMID: 39901067
Background: The eradication of the Hepatitis C Virus (HCV) reduce the risk of liver cancer (LC), but lifestyle changes after cure may counterbalance its benefit. Our study investigates lifestyle changes...
2.
Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO study
Trujillo-Santos J, Garcia-Escobar I, Salgado M, Araujo A, Martinez-de-Castro E, Molina R, et al.
Oncologist . 2024 Dec; PMID: 39673414
Background: Venous thromboembolism (VTE) is one of the leading causes of death in patients with cancer. Currently, there is a need to develop an easily applicable risk model that can...
3.
Clinical and subclinical arteriosclerotic disease in octagenarians with hip fracture. A case-control study
Capdevila-Reniu A, Navarro-Lopez M, Sierra-Benito C, Sapena V, Suarez-Lombrana A, Camafort-Babkowski M, et al.
Med Clin (Barc) . 2024 Jul; 163(9):431-435. PMID: 38987112
Background And Objectives: Evaluate clinical and subclinical arteriosclerotic disease in older patients with hip fracture compared with patients without fracture in order to increase knowledge about the relation between both...
4.
Incidence of Liver and Non-liver Cancers After Hepatitis C Virus Eradication: A Population-Based Cohort Study
Rios J, Sapena V, Marino Z, Bruix J, Forns X, Morros R, et al.
Drugs Real World Outcomes . 2024 Jun; 11(3):389-401. PMID: 38874848
Background And Objectives: Direct-acting antivirals (DAAs) offer a high rate of hepatitis C virus (HCV) eradication. However, concerns on the risk of cancer after HCV eradication remain. Our study aimed...
5.
Magnetic Resonance Imaging Features Indicative of Permanent Colon Damage in Ulcerative Colitis: An Exploratory Study
Rimola J, Castro-Poceiro J, Sapena V, Aduna M, Arevalo J, Vera I, et al.
J Crohns Colitis . 2024 May; 18(10):1690-1700. PMID: 38767057
Background And Aims: It is uncertain whether ulcerative colitis leads to accumulated bowel damage on cross-sectional image. We aimed to characterise bowel damage in patients with ulcerative colitis using magnetic...
6.
MRI Using Gadoxetic Acid in the Work-Up of Liver Nodules Not Conclusively Benign in Budd-Chiari Syndrome: A Prospective Long-Term Follow-Up
Garcia-Criado A, Rimola J, Seijo S, Darnell A, Belmonte E, Sapena V, et al.
Liver Cancer . 2024 May; 13(2):203-214. PMID: 38751551
Introduction: The incidence of hepatocellular carcinoma (HCC) in Budd-Chiari syndrome (BCS) is unknown and there is no validated diagnostic work-up to define the liver nodules with arterial phase hyperenhancement (APHE),...
7.
Influence of further decompensation on survival across clinical stages of decompensated cirrhosis: The role of portal hypertension and HVPG changes
Garcia-Guix M, Ardevol A, Sapena V, Alvarado-Tapias E, Huertas A, Brujats A, et al.
Liver Int . 2024 Apr; 44(8):1971-1989. PMID: 38634685
Background And Aims: Decompensated-cirrhosis encompasses several stages with different prognosis, such as bleeding, ascites and bleeding-plus-ascites. Development of further-decompensation worsens survival, while non-selective β-blockers (NSBBs) can modify the risk. However,...
8.
Validation of the Back-table Graft Arterial Anastomosis between the Splenic Artery and Superior Mesenteric Artery: Arterial Complications after a 21-year Single-center Experience of Pancreas Transplantation
Ferrer-Fabrega J, Cardenas G, Sapena V, Garcia-Criado A, Barrufet M, Perez C, et al.
Ann Surg . 2023 Dec; PMID: 38146951
Objective: To determine the role of the arterial splenomesenteric anastomosis (ASMA) vascular reconstruction technique in terms of arterial vascular complications in pancreas transplant (PT) recipients. Summary Background Data: The ASMA...
9.
Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant data
Villanueva C, Sapena V, Lo G, Seo Y, Shah H, Singh V, et al.
Aliment Pharmacol Ther . 2023 Dec; 59(3):306-321. PMID: 38108646
Background & Aims: Non-selective β-blockers (NSBBs) and endoscopic variceal-ligation (EVL) have similar efficacy preventing first variceal bleeding. Compensated and decompensated cirrhosis are markedly different stages, which may impact treatment outcomes....
10.
Risk of Treatment Failure and Death after Ablation in Hepatocellular Carcinoma Patients-A Multiparametric Prediction
Munoz-Martinez S, Sapena V, Garcia-Criado A, Darnell A, Forner A, Belmonte E, et al.
Cancers (Basel) . 2023 Jul; 15(13). PMID: 37444380
Background: Ablation is a first-line treatment for Barcelona Clinic Liver Cancer (BCLC)-0/A hepatocellular carcinoma (HCC). However, there are scarce data about patients' outcomes after recurrence. The present study evaluates the...